Travere Therapeutics (TVTX) Return on Capital Employed Growth (1y) (2014 - 2026)
Travere Therapeutics (TVTX) Return on Capital Employed Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,440.76 Bn | 66,440.47 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,909.20 Bn | 1,909.14 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 468.28 Bn | 463.49 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.49 Bn | 115.24 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.26 Bn | 61.51 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.88 Bn | 62.88 Bn | - | - |
| 8 | Argenx Se | 55.67 Bn | 50.48 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.37 Bn | 34.36 Bn | 959.66 Mn | 2,400.00 |
| 10 | Travere Therapeutics | 5.23 Bn | 5.23 Bn | 125.25 Mn | 4,587.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4,587.00 |
| Dec 31, 2025 | 7,767.00 |
| Sep 30, 2025 | 8,368.00 |
| Jun 30, 2025 | 3,350.00 |
| Mar 31, 2025 | 1,934.00 |
| Dec 31, 2024 | -3,160.00 |
| Sep 30, 2024 | -4,681.00 |
| Jun 30, 2024 | -2,279.00 |
| Mar 31, 2024 | -2,115.00 |
| Dec 31, 2023 | -393.00 |
| Sep 30, 2023 | -786.00 |
| Jun 30, 2023 | -1,891.00 |
| Mar 31, 2023 | -2,384.00 |
| Dec 31, 2022 | -2,679.00 |
| Sep 30, 2022 | -1,514.00 |
| Jun 30, 2022 | -576.00 |
| Mar 31, 2022 | 196.00 |
| Dec 31, 2021 | 102.00 |
| Sep 30, 2021 | -2,193.00 |
| Jun 30, 2021 | -1,541.00 |